The Association Between Psychotropic Medications and Cognitive Functioning in a Real-World Cohort of 869 Individuals with Schizophrenia.

Journal: Schizophrenia bulletin
Published Date: May 8, 2025

Abstract

BACKGROUND: Cognitive deficits are a central feature of schizophrenia for which there are not any established pharmacological treatments. Antipsychotics are the mainstay of schizophrenia therapy but the effects of these and other psychotropic medications on the cognitive functioning of people schizophrenia have not been extensively studied in routine real-world settings.

Authors

  • Faith Dickerson
    The Stanley Research Program at Sheppard Pratt, Baltimore, MD 21204, United States.
  • Andrea Origoni
    The Stanley Research Program at Sheppard Pratt, Baltimore, MD 21204, United States.
  • Emily Katsafanas
    The Stanley Research Program at Sheppard Pratt, Baltimore, MD 21204, United States.
  • Kelly Rowe
    The Stanley Research Program at Sheppard Pratt, Baltimore, MD 21204, United States.
  • Sabahat Khan
    The Stanley Research Program at Sheppard Pratt, Baltimore, MD 21204, United States.
  • Allana Therese Calahatian
    The Stanley Research Program at Sheppard Pratt, Baltimore, MD 21204, United States.
  • Fahad Mukhtar
    The Stanley Research Program at Sheppard Pratt, Baltimore, MD 21204, United States.
  • Robert Yolken
    The Stanley Neurovirology Laboratory, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, MD 21205, United States.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals